NCT07039110View on ClinicalTrials.gov

Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

RecruitingOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

September 9, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Plaque Psoriasis
Trial Locations (7)

R3M 3Z4

RECRUITING

Wiseman Dermatology Research /ID# 276847, Winnipeg

L1S 7K8

RECRUITING

Cca Medical Research /ID# 276944, Ajax

L8N 1Y2

RECRUITING

Dermatrials Research /ID# 276714, Hamilton

N6A 5R9

RECRUITING

Lovegrove Dermatology /ID# 276797, London

L3P 1X2

RECRUITING

Lynderm Research Inc /ID# 276755, Markham

L6H 6P8

RECRUITING

Rejuvenation Dermatology Clinic Oakville /ID# 277492, Oakville

M2N 3A6

RECRUITING

North York Research Inc /ID# 276835, Toronto

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY